Former BioNTech CFO Michael Kring joins Cellbricks as Chief Financial Officer

January 07, 2025 – Berlin, Germany

Cellbricks is proud to announce the appointment of Michael Kring  as its new Chief Financial Officer.

Michael brings decades of financial leadership in the biotech and life-sciences startup space. As the founder of High Tech Services GmbH and former Group CFO of BioNTech SE, he has played a pivotal role in scaling some of Europe’s most innovative science-driven companies. Beyond his expertise in finance, controlling, and operations, Michael brings with him a powerful network across the bio- and deeptech investment landscape – opening new opportunities for Cellbricks.

Cellbricks knows that breakthrough science needs strong strategic and financial foundations. With Michael on board, the company is well-positioned to scale its impact and navigate the journey from lab to clinic with precision.

“We are pleased to welcome Michael to the Cellbricks team,” said Alexander Leutner, Co-CEO of Cellbricks. “He will ensure that the financial direction of Cellbricks remains in line with our strategy and long-term vision.”